Neoneuro

Provider of aptamer-based molecular diagnostics for Alzheimer's Disease

placeParis, Ile De France, France calendar_todayFounded 2014 language neoneuro-aptamers.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace dormant. Cited 28 times.

YearFilings
20181
20191
20202

Social engagement

Social engagement: 1.2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Alzheimer's Drug Discovery.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

8 Apr 2026
Product launch
Aptamarker platform
24 Mar 2026
Product launch
Aptamarker Inflammation panel
10 Mar 2026
Event
BioEurope Spring 2026
Coming soon